New research has found that a drug commonly used to treat a broad range of fungal infections, including skin and nail infections, has a lot of potential as a new cancer treatment. Itraconazole, a generic anti-fungal agent that costs relatively less, shows some evidence of efficacy in metastatic prostate cancer -- which would make it an attractive proposition given the high costs associated with cancer treatments such as arbiraterone, said Pan Pantziarka, member ...Thursday 16 April 2015
Common Anti-fungal Drug, Itraconazole, Shows Potential in Cancer Treatment
New research has found that a drug commonly used to treat a broad range of fungal infections, including skin and nail infections, has a lot of potential as a new cancer treatment. Itraconazole, a generic anti-fungal agent that costs relatively less, shows some evidence of efficacy in metastatic prostate cancer -- which would make it an attractive proposition given the high costs associated with cancer treatments such as arbiraterone, said Pan Pantziarka, member ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment